DUBLIN /PRNewswire/ --
The "Global Pediatric Vaccine Market - Technologies, Market share and Industry Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
Global pediatric vaccine market is expected to grow with a CAGR of around 12.6% over the forecast period 2017-2024
Key factors contributing the growth of global pediatric vaccine market includes, rise in importance and awareness of immunization across the globe predominance of chronic diseases, technologic advancements and increase in government and non-government funding.
However, cost of immunization and of healthcare infrastructure are some of the growth restricting factor in the market. Whereas, rising concern regarding diseases which are vaccine-preventable across the globe is a key opportunity in the market. Moreover, lack of awareness regarding diseases in the remote areas is expected to deliver challenge towards the market.
Rise in importance and awareness of immunization across the globe over the forecast period is the major factor attributing the growth of the market. Global governments and non-government organizations are focusing efforts regarding vaccine preventable diseases to increase awareness globally. For instance, programs by World Health Organization, Gavi, Pan America Health Organization, Center for Disease Control and Prevention etc., are providing significant awareness and aids in the immunization field to increase the healthcare in children. As the result of continuous awareness programs and immunization programs across the world, prevalence of polio has decreased in several countries almost by 99% since 1988.
Only 3 countries that are Nigeria, Pakistan and Afghanistan are polio-endemic countries left. In 2016, around 86% of global children population has received 3 doses of diphtheria-tetanus-pertussis (DTP1) vaccination. Increasing vaccination programs and rising need for preventing fatal disease has significantly increased the adoption of vaccination. However, lack of healthcare infrastructure is a global pediatric vaccine major factor restricting growth of the market.
Global pediatric vaccine market is segmented into type, technology and application. On the basis of type market is segmented into monovalent and multivalent. Further on the basis of technology market is segmented into live attenuated, inactivated, subunit, toxoid, conjugate and others. Similarly, on the basis of application, global pediatric vaccines market segregated into infectious disease, cancer and allergy.
Geographically, market is segmented into North America, Asia Pacific, Europe and Rest of the world. North America is expected to dominate the global pediatric vaccine over the forecast period 2017-2024 by holding largest market share in terms of revenue. Rise in the research and development activities in the region is major factor attributing the regional market growth. Also, various investments by market players and government for increasing vaccination is expected to contribute towards the growth of the pediatric vaccine market. However, Asia Pacific is expected to register fastest growth over the forecast period 2017-2024.
Key Topics Covered:
1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology
2. Market Overview
2.1. Global Pediatric Vaccines Market: Evolution & Transition
2.2. Market Definition & Scope
2.3. Industry Structure
2.4. Regulatory Framework
2.5. Total Market Analysis
2.5.1. Top 5 Findings
2.5.2. Top 5 Opportunity Markets
2.5.3. Top 5 Companies
2.5.4. Top 3 Competitive Strategies
2.6. Estimation Analysis
2.7. Strategic Analysis
2.7.1. Investment Vs. Adoption Model
2.7.2. 360-Degree Industry Analysis
2.7.3. Porters 5 Force Model
2.7.4. See-Saw Analysis
2.7.5. Consumer Analysis And Key Buying Criteria
2.8. Competitive Analysis
2.8.1. Market Share Analysis & Top Company Analysis
2.9. Strategic Recommendations & Key Conclusion
2.9.1. Investment Opportunities By Regions
2.9.2. Opportunities In Emerging Applications
2.9.3. Investment Opportunity In Fastest Growing Segment
3. Market Determinants
3.1. Market Drivers
3.1.1. Increasing Awareness Regarding Immunization
3.1.2. Increasing Prevalence Of Chronic Diseases
3.1.3. Technological Advancements
3.1.4. Growing Government Support For Vaccination
3.2. Market Restraints
3.2.1. Cost Of Immunization
3.2.2. Lack Of Healthcare Infrastructure
3.3. Market Opportunities
3.3.1. Rising Concern Against Vaccine-Preventable Diseases
3.3.2. Decreasing Cost Of Vaccination
3.4. Market Challenges
3.4.1. Lack Of Awareness Regarding Diseases In The Remote Areas
4. Global Pediatric Vaccines Market By Type
4.1. Market Definition And Scope
4.2. Decision Support Database & Estimation Methodology
4.3. Comparative Analysis Across Market Segments
4.4. Opportunity Matrix
4.5. Market Segmentation
4.5.1. Global Monovalent Market
4.5.2. Global Multivalent Market
5. Global Pediatric Vaccines Market By Technology
5.1. Market Definition And Scope
5.2. Decision Support Database & Estimation Methodology
5.3. Comparative Analysis Across Market Segments
5.4. Opportunity Matrix
5.5. Market Segmentation
5.5.1. Global Live Attenuated Market
5.5.2. Global Inactivated Market
5.5.3. Global Subunit Market
5.5.4. Global Toxoid Market
5.5.5. Global Conjugate Market
5.5.6. Global Others Market
6. Global Pediatric Vaccines Market By Application
6.1. Market Definition And Scope
6.2. Decision Support Database & Estimation Methodology
6.3. Comparative Analysis Across Market Segments
6.4. Opportunity Matrix
6.5. Market Segmentation
6.5.1. Global Infectious Disease Market
6.5.2. Global Cancer Market
6.5.3. Global Allergy Market
7. Competitive Landscape
7.1. Key Strategies
7.1.1. List Of Mergers And Acquisitions
7.1.2. List Of Joint Ventures
7.1.3. List Of Product Launches
7.1.4. List Of Partnerships
8. Geographic Analysis
8.1. Decision Support Database & Estimation Methodology
8.2. Comparative Analysis Across Market Segments
8.3. Opportunity Matrix
8.4. Global Pediatric Vaccines Market By Region 2015-2024
9. Company Profiles
- Astrazeneca. (U.S.)
- Bio Med Pvt. Ltd. (India)
- Changchun Changshen Life Sciences Ltd. (China)
- Glaxosmithkline (U.K.)
- Indian Immunologicals Limited (India)
- Intercell AG (Austria)
- Merck Sharp & Dohme Corp. (U.S.)
- Mitsubishi Tanabe Pharma Corporation (Japan)
- Panacea Biotec (India)
- Pfizer, Inc. (U.S.)
- Sanofi (France)
- Serum Institute Of India Pvt. Ltd. (India)
- Sinovac Biotech Ltd. (China)
- VFC Corporation (U.S.)
- Zydus Cadila (India)
For more information about this report visit https://www.researchandmarkets.com/research/s3jkwd/global_pediatric?w=5
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
